Today’s guest is Emmanuel Walckenaer, CEO of YSEOP. A firm based in Paris, YSEOP focuses on natural language generation across financial services and life sciences industries. Emmanuel speaks with us this week about the applications of NLG when it comes to drug discovery and life sciences. Emmanuel also discusses some other life sciences and AI trends that he thinks are promising and some of the trends that he’s seen in his work in the life sciences space. This episode is sponsored by YSEOP. If you’re interested in reaching the Emerj audience, you have an important educational message about use-cases and applications of AI, be sure to contact us at emerj.com/ad1.

Automating Critical Drug Discovery Processes with NLP - with Emmanuel Walckenaer of YSEOP

The AI in Business Podcast is for non-technical business leaders who need to find AI opportunities, align AI capabilities with strategy, and deliver ROI.

Each week, Emerj Artificial Intelligence Research CEO Daniel Faggella interviews top AI executives from Fortune 500 firms and unicorn startups - to uncover trends, use-cases, and best practices for practical AI adoption.

Subscribe to Emerj's weekly AI newsletter by downloading our "Beginning with AI" PDF guide: https://emerj.com/beg1

Technology

Tech News

Podcasting

Gadgets

Software How-To

Business

Investing

Careers

Management & Marketing

Business News

Shopping

Management

Today’s guests are Arkestro Founder & Chief Strategy Officer Edmund Zagorin and Johnson & Johnson Chief Procurement Officer Len DeCandia. Arkestro is an AI-driven startup in the procurement space with broad partnerships across the automotive, construction, and manufacturing sectors, including Johnson & Johnson and Koch Industries. Together, the two discuss procurement from a distinct leadership perspective and the broad range of challenges, from keeping talent ahead of scaling to the post-pandemic realities of recovering supply chains. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Guidance for Procurement Leaders in Recovering Supply Chains - with Edmund Zagorin of Arkestro and Len DeCandia of Johnson & Johnson

Today’s guest is Chris Helsel, Senior Vice President of Global Operations and Chief Technology Officer at The Goodyear Tire & Rubber Company. Despite the disparity in the predictions about self-driving cars that were made a decade ago, the era of automated transportation is close at hand. Chris joins the podcast today to discuss the enormous implications of the transition for numerous industries, from consumer goods to manufacturing and retail, and every industry that touches on transportation. To access Emerj’s frameworks for AI readiness, ROI, and strategy, visit Emerj Plus at emerj.com/p1.

Tires and Data Collection for Autonomous Vehicles - with Chris Helsel of Goodyear

Today’s guest is Dr. John Almasan, Head of AI & Emerging Technologies at TIAA. TIAA, or the Teachers Insurance and Annuity Association of America-College Retirement Equities Fund, is a US-based insurance provider specializing in retirement services in areas like academia, research, healthcare, and government. Dr. Almasan joins Emerj CEO and Head of Research Daniel Faggella on today’s podcast to discuss AI in insurance with a focus on governance, talent, and innovation. Together, they cover practical use cases in customer experience, fraud detection, and marketing throughout the episode. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

GenAI for CX, Cybersecurity, Fraud Detection, and Marketing Workflows in Insurance - with Dr. John Almasan of TIAA

Today’s guest is Shreyas Becker, Head of AI & Data Products, Manufacturing & Supply at Sanofi. Shreyas joins Emerj Senior Editor Matthew DeMello on today’s podcast to talk about alleviating pain points for supply chain leaders in life sciences spaces. From building systems that deliver “real world evidence” to the subject matter experts and managers who need it to the pros and cons of sharing sensorial data with big tech data storage platforms like Amazon Web Services – Shreyas helps the executive podcast audience understand how problems are both viewed and solved through the lens of data, from no matter where they arise. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

AI for Supply Chain Challenges in Life Sciences - with Shreyas Becker of Sanofi

Today’s guest is Daniel Ferrante, AI Leader in R&D; and Data Strategy at Deloitte. Together with Emerj CEO and Head of Research Daniel Faggella, they delve into the complex challenges in AI adoption that major pharmaceutical firms encounter with cultural shifts, technological complexities, and the difficulties in monetizing data and aligning teams efficiently. Additionally, the pair explores the future landscape of phenotypical drug discovery, drawing insights from the context of COVID-19. Their focus underscores the critical importance of collecting and analyzing data to yield actionable insights, especially in the healthcare sector and amidst global health crises. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Automating Critical Drug Discovery Processes with NLP - with Emmanuel Walckenaer of YSEOP

Download our free app to listen on your phone